BIOADVANTEX PHARMA INC has a total of 20 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Israel, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals are GOSFORTH CT HOLDINGS PTY LTD, MEDIPEARL PTE LTD and PLETNEV VLADIMIR VLADIMIROVICH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Brazil | 2 | |
#4 | Japan | 2 | |
#5 | Mexico | 2 | |
#6 | Australia | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | New Zealand | 1 | |
#11 | United States | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Fleshner Neil E | 8 |
#2 | Andrus James | 5 |
#3 | Herzenberg Leonore A | 4 |
#4 | Herzenberg Leonard A | 4 |
#5 | De Rosa Stephen C | 3 |
#6 | Leonore A Herzenberg | 2 |
#7 | Aiello David | 1 |
#8 | Montavani John J | 1 |
#9 | Leonard A Herzenberg | 1 |
#10 | Neil E Fleshner | 1 |
Publication | Filing date | Title |
---|---|---|
WO2005017094A2 | N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency | |
US6670392B2 | Compositions and methods for the prevention and treatment of human prostate cancer |